Summary

Your HLA-DQA1 result tells you whether you carry the immune machinery (HLA-DQ2.5) that makes celiac disease possible — roughly 95% of celiac patients carry this marker, but so do ~30% of the general population who never develop the disease, making this a necessary but not sufficient risk factor that should inform awareness, not anxiety.

Genotype spectrum

CC (non-carrier)

Near-complete celiac exclusion. If you've ever worried about gluten sensitivity, this result is powerfully reassuring.

CT (HLA-DQ2.5 carrier, heterozygous)

Awareness is your advantage. You know your immune system CAN react to gluten — most people who develop celiac disease spend years with unexplained symptoms before diagnosis because nobody thought to test.

TT (HLA-DQ2.5 homozygous)

Maximum clarity for proactive monitoring. You carry the strongest genetic predisposition, which means if celiac does develop, you are most likely to catch it early because you know to look.

Practical takeaway

For CT/TT Carriers (HLA-DQ2.5 Positive)

Do NOT go gluten-free preventively.
This is the most important practical point. There is no evidence that preventive gluten avoidance reduces celiac disease risk — and it makes diagnosis impossible because:
• tTG-IgA antibodies (the primary screening test) normalise within weeks of gluten withdrawal
• Intestinal biopsy may show partial recovery, making histological diagnosis uncertain
• You need to be eating at least 3g of gluten/day (~2 slices of bread) for 6+ weeks before testing is reliable

Know the symptoms — both classic and atypical:

Classic GI presentation: chronic diarrhoea, steatorrhoea (fatty stools), bloating, abdominal pain, weight loss, failure to thrive (children).

Atypical presentation (more common in adults): iron deficiency anaemia unresponsive to supplementation, unexplained folate or B12 deficiency, chronic fatigue, osteoporosis or osteopenia (especially if premenopausal), elevated liver transaminases without other cause, recurrent mouth ulcers, dermatitis herpetiformis (pathognomonic blistering rash), peripheral neuropathy, cerebellar ataxia, infertility or recurrent miscarriage, dental enamel defects.

When to test:
• Any of the above symptoms without clear explanation → request tTG-IgA while eating gluten
• Annual or biennial screening may be reasonable for TT homozygotes, especially if first-degree relatives have celiac disease
• If tTG-IgA is positive: referral for duodenal biopsy (current gold standard for definitive diagnosis in adults)

If diagnosed with celiac disease:
• Strict lifelong gluten-free diet is the only treatment. This means zero wheat, barley, rye, and cross-contaminated oats.
• Intestinal healing typically occurs within 6-24 months on a strict gluten-free diet.
• Iron, folate, B12, calcium, and vitamin D levels should be checked and repleted.
• Bone density scan if diagnosis is delayed (malabsorption may have caused bone loss).
• Annual follow-up with tTG-IgA to confirm adherence and mucosal healing.

Family implications:
• First-degree relatives of celiac patients have a 10-15% risk of celiac disease. If you're CT or TT and a relative has celiac, your risk is at the higher end

Evidence detail

What This Gene Does

HLA-DQA1 is part of the HLA (Human Leukocyte Antigen) system — your immune system's identity-checking machinery. HLA molecules sit on the surface of immune cells and present fragments of proteins (peptides) to T cells, which then decide whether to attack or ignore them. Your specific HLA type determines which peptides your immune system can "see."

HLA-DQ2.5 (encoded by the DQA105:01/DQB102:01 haplotype, tagged by rs2187668) has a binding groove that fits deamidated gluten peptides with unusually high affinity. When gluten-derived peptides are presented by DQ2.5 to T cells in the gut, the immune system can mount a sustained inflammatory response against the intestinal lining — this is celiac disease. Without DQ2.5 (or the less common DQ8), your immune system literally cannot "see" gluten in the way that triggers celiac disease.

Mechanism

Celiac disease requires three things to converge: genetic susceptibility (HLA-DQ2.5 or DQ8), gluten exposure, and an environmental trigger. Here's how the mechanism works:

1. Gluten ingestion: Wheat, barley, and rye contain storage proteins (gliadins and glutenins in wheat) that are rich in proline and glutamine — making them resistant to full digestion by human proteases. Partially digested gluten peptides (notably a 33-mer gliadin fragment) survive into the small intestine largely intact.

2. Tissue transglutaminase (tTG) deamidation: tTG, an enzyme in the intestinal submucosa, converts glutamine residues in gluten peptides to glutamic acid (deamidation). This modification is critical — deamidated gluten peptides fit the HLA-DQ2.5 binding groove with dramatically higher affinity than native peptides.

3. HLA-DQ2.5 presentation: Antigen-presenting cells (dendritic cells, macrophages) bearing HLA-DQ2.5 load the deamidated gluten peptides into the DQ2.5 binding groove and present them to CD4+ T cells in the intestinal lamina propria.

4. T cell activation: Gluten-reactive CD4+ T cells recognise the DQ2.5-gluten complex. This triggers a full adaptive immune response: pro-inflammatory cytokine release (IFN-gamma, IL-21, IL-15), activation of cytotoxic intraepithelial lymphocytes, and recruitment of B cells that produce anti-tTG and anti-gliadin antibodies.

5. Intestinal damage: The immune response destroys intestinal villi (villous atrophy), deepens crypts (crypt hyperplasia), and increases intraepithelial lymphocyte infiltration. This reduces absorptive surface area → malabsorption of iron, folate, B12, calcium, fat-soluble vitamins, and other nutrients.

Why DQ2.5 homozygotes have higher risk:

Two copies of DQ2.5 mean more DQ2.5 molecules on antigen-presenting cells → more gluten peptide presentation → stronger T cell activation → lower threshold for disease initiation. This is a genuine dose-response at the molecular level.

Why most carriers never develop disease:

The immune response requires an initiating event — possibly a viral gut infection (reovirus has been implicated), altered gut permeability, or microbiome disruption — that breaks tolerance to gluten in the gut. Without this trigger, the immune system ignores gluten despite having the capacity to react. Think of HLA-DQ2.5 as a loaded gun — it still needs a trigger pull.

HLA-DQA1 Dqa1 Coeliac

Summary

Genotype spectrum

Practical takeaway

Evidence detail

Sources (7)